Literature DB >> 14996199

The molecular basis of the Rhesus antigen Ew.

Erwin Strobel1, France Noizat-Pirenne, Sabine Hofmann, Jean Pierre Cartron, Matthias F Bauer.   

Abstract

BACKGROUND: The Rhesus antigen Ew (ISBT designation 004 011) was first described in 1955. It is defined by a specific antibody, but its molecular genetic basis has not yet been resolved. STUDY DESIGN AND METHODS: Two individuals serologically characterized to express the rare Rhesus antigen Ew were analyzed by sequencing of all 10 exons of the RHCE gene.
RESULTS: A nucleotide exchange at position 500 (T500A) resulting in a Met167Lys amino acid substitution was found in both individuals. Moreover, we show that an individual carrying the Ew antigen is capable to produce an alloantibody against the wild-type E antigen.
CONCLUSION: The single-point mutation T500A in exon 4 of the RHCE gene is a molecular basis of the rare Rhesus antigen Ew.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14996199     DOI: 10.1111/j.1537-2995.2004.00655.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  4 in total

Review 1.  Molecular genetics and clinical applications for RH.

Authors:  Willy A Flegel
Journal:  Transfus Apher Sci       Date:  2011-01-28       Impact factor: 1.764

2.  Weak D in the Tunisian population.

Authors:  Mouna Ouchari; Houda Romdhane; Taher Chakroun; Saida Abdelkefi; Batoul Houissa; Slama Hmida; Saloua Jemni Yacoub
Journal:  Blood Transfus       Date:  2014-10-23       Impact factor: 3.443

3.  RhCE protein variants in Southwestern Germany detected by serologic routine testing.

Authors:  Peter Bugert; Erwin A Scharberg; Christof Geisen; Inge von Zabern; Willy A Flegel
Journal:  Transfusion       Date:  2009-05-18       Impact factor: 3.157

4.  Rh Ew antigen in a multi-transfused patient with sickle cell disease.

Authors:  Vitor Mendonça Alves; Paulo Roberto Juliano Martins; Fernanda Bernadelli De Vito; Lilian Castilho; Helio Moraes-Souza
Journal:  Hematol Transfus Cell Ther       Date:  2018-04-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.